Pharmaceuticals - Indian - Bulk Drugs
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 137.18 | 115.58 | 100.05 | 71.15 | 39.42 |
Total Expenses | 121.97 | 102.62 | 91.42 | 67.38 | 38.18 |
Profit Before Tax | 15.21 | 12.95 | 8.63 | 3.77 | 1.24 |
Profit After Tax | 11.50 | 9.82 | 6.69 | 2.73 | 0.87 |
Operating Profit after Depreciation | 17.40 | 16.06 | 10.33 | 4.92 | 2.48 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 19.64 | 18.81 | 4.20 | 4.72 | 4.16 |
Total Non Current Assets | 20.44 | 19.30 | 15.32 | 8.71 | 4.27 |
Total Current Assets | 65.01 | 51.31 | 43.68 | 25.47 | 18.17 |
TOTAL ASSETS | 85.45 | 70.61 | 59 | 34.18 | 22.45 |
Total Shareholder's Fund | 58.78 | 22.56 | 13.10 | 7.02 | 4.25 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | -13.04 | 8.59 | 11.80 | 7.29 | 3.03 |
Net Cash used in Investing Activities | -3.79 | -4.96 | -6.63 | -5 | -1.05 |
Net Cash used in Financing Activities | 22.77 | -3.10 | -1.70 | -1.16 | -1.24 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 123.98 | 102.65 | 74.96 | 55.18 | 36.61 |
Total Expenses | 109.12 | 90.38 | 67.56 | 51.42 | 35.22 |
Profit Before Tax | 14.86 | 12.26 | 7.41 | 3.76 | 1.39 |
Profit After Tax | 11.09 | 9.15 | 5.50 | 2.72 | 1.02 |
Operating Profit after Depreciation | 16.64 | 15.26 | 9.06 | 4.88 | 2.62 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 16.47 | 15.58 | 3.74 | 4.25 | 4.16 |
Total Non Current Assets | 17.51 | 16.41 | 15.12 | 8.50 | 4.53 |
Total Current Assets | 60.23 | 44 | 33.93 | 22.31 | 16.05 |
TOTAL ASSETS | 77.74 | 60.42 | 49.06 | 30.81 | 20.58 |
Total Shareholder's Fund | 57.75 | 21.70 | 12.55 | 7.05 | 4.32 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | -15.03 | 7.35 | 9.14 | 6.82 | 2.32 |
Net Cash used in Investing Activities | -3.29 | -2.58 | -7.17 | -4.59 | -1.08 |
Net Cash used in Financing Activities | 23.19 | -3 | -1.66 | -1.12 | -1.23 |
No data available
No data available
Company | Price | Market Cap (in ₹ Cr) |
---|---|---|
Infinium Pharmachem Ltd | ₹238 | ₹370.88 |
Sun Pharmaceuticals Industries Ltd | ₹1,613.65 | ₹3,87,168.69 |
Divis Laboratories Ltd | ₹5,725.20 | ₹1,51,986.07 |
Cipla Ltd | ₹1,463.25 | ₹1,18,174.12 |
Torrent Pharmaceuticals Ltd | ₹3,028.40 | ₹1,02,490.21 |
Mankind Pharma Ltd | ₹2,337.05 | ₹96,421.67 |
On 14 November 2024
07 Nov 2024, 03:30 pm
On 23 October 2024
03 Oct 2024, 03:28 pm
On 1 October 2024
27 Sep 2024, 10:46 am
On 28 September 2024
04 Sep 2024, 10:54 am
On 2 September 2024
24 Aug 2024, 10:50 am